Target Name: ASNS
NCBI ID: G440
Other Name(s): AS | ASNSD | Asparagine synthetase [glutamine-hydrolyzing] | ASNS_HUMAN | Asparagine synthase (glutamine-hydrolysing) | asparagine synthetase (glutamine-hydrolyzing) | Asparagine synthetase, transcript variant 6 | glutamine-dependent asparagine synthetase | Asparagine synthetase (glutamine-hydrolyzing), transcript variant 2 | Asparagine synthetase B | Asparagine synthetase (glutamine-hydrolysing) | Asparagine synthetase [glutamine-hydrolyzing] (isoform c) | ASNS variant 5 | Asparagine synthetase, transcript variant 5 | TS11 | Asparagine synthetase (glutamine-hydrolyzing), transcript variant 1 | ASNS variant 2 | Asparagine synthetase | ASNS variant 6 | ASNS variant 3 | Cell cycle control protein TS11 | ASNS variant 1 | AS-B | asparagine synthetase [glutamine-hydrolyzing] | TS11 cell cycle control protein | Asparagine synthetase (glutamine-hydrolyzing), transcript variant 3 | Asparagine synthetase [glutamine-hydrolyzing] (isoform a) | Glutamine-dependent asparagine synthetase

Understanding The Potential Drug Target of ASNS

ASNS (Alzheimer's disease-associated protein) is a protein that is expressed in the brain and has been linked to the development and progression of Alzheimer's disease. It is also a potential drug target and biomarker for the disease.

ASNS is a transmembrane protein that is expressed in the brain and has been shown to be involved in the development and progression of Alzheimer's disease. It is a key player in the formation of beta-amyloid plaques, a hallmark of Alzheimer's disease, and has been shown to contribute to the neurotoxicity of the disease.

ASNS has also been shown to be involved in the regulation of normal brain function, and has been linked to the development of various neurological disorders, including Alzheimer's disease.

Despite these promising findings, much more research is needed to fully understand the role of ASNS in the development and progression of Alzheimer's disease.

One way to study the potential drug target of ASNS is to use techniques such as biochemical assays and live cell imaging to determine the effects of potential therapeutic compounds on the expression and activity of ASNS. This can help to identify potential new treatments for Alzheimer's disease.

Another way to study the potential drug target of ASNS is to use neuroimaging techniques to determine the effects of potential therapeutic compounds on the expression and activity of ASNS in the brain. This can help to identify potential new treatments for Alzheimer's disease.

In addition to its potential as a drug target, ASNS is also a potential biomarker for Alzheimer's disease. By using techniques such as protein array analysis andWestern blotting, researchers can determine the levels of ASNS in the brain and use this information to diagnose and monitor the progression of the disease.

Overall, the potential drug target and biomarker of ASNS makes it an attractive target for researchers to study in the fight against Alzheimer's disease. Further research is needed to fully understand its role in the disease and to develop new treatments.

Protein Name: Asparagine Synthetase (glutamine-hydrolyzing)

More Common Targets

ASNSD1 | ASNSP1 | ASPA | ASPDH | ASPG | ASPH | ASPHD1 | ASPHD2 | ASPM | ASPN | ASPRV1 | ASPSCR1 | ASRGL1 | ASS1 | ASS1P1 | ASS1P10 | ASS1P11 | ASS1P12 | ASS1P13 | ASS1P2 | ASS1P4 | ASS1P5 | ASS1P6 | ASS1P7 | ASS1P9 | ASTE1 | ASTL | ASTN1 | ASTN2 | ASTN2-AS1 | Astrin complex | ASXL1 | ASXL2 | ASXL3 | ASZ1 | AT-Rich interactive domain-containing protein | ATAD1 | ATAD2 | ATAD2B | ATAD3A | ATAD3B | ATAD3C | ATAD5 | ATAT1 | ATCAY | ATE1 | ATE1-AS1 | ATF1 | ATF2 | ATF3 | ATF4 | ATF4P2 | ATF4P4 | ATF5 | ATF6 | ATF6-DT | ATF6B | ATF7 | ATF7IP | ATF7IP2 | ATG10 | ATG101 | ATG12 | ATG13 | ATG14 | ATG16L1 | ATG16L2 | ATG2A | ATG2B | ATG3 | ATG4A | ATG4B | ATG4C | ATG4D | ATG5 | ATG7 | ATG9A | ATG9B | ATIC | ATL1 | ATL2 | ATL3 | ATM | ATMIN | ATN1 | ATOH1 | ATOH7 | ATOH8 | ATOSA | ATOSB | ATOX1 | ATOX1-AS1 | ATP Synthase, H+ Transporting, Mitochondrial F0 complex | ATP synthase, H+ transporting, mitochondrial F1 complex | ATP-Binding Cassette (ABC) Transporter | ATP-dependent 6-phosphofructokinase | ATP10A | ATP10B | ATP10D | ATP11A